Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Image: The New York Times
ad slot · in-content video 16:9
Coverage
Wires & papers of record
- Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.